Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Enrolling by invitation
Conditions studied: Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis
In brief
The aim of this study is to evaluate the effectiveness and safety of Natural Matrix Protein™ (NMP™) fibers when used in cervical or lumbar interbody fusion in patients with degenerative disc disease (DDD), spinal stenosis, spondylolisthesis undergoing cervical or lumbar interbody spine fusion at no more than 3 adjacent levels.
Key facts
- Study ID
- NCT06000319
- Run by
- Induce Biologics USA Inc.
- People needed
- 200
- Starts
- 2024-01-04
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2025-11-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject was diagnosed with DDD, spinal stenosis, or spondylolisthesis;
- Subject has undergone cervical or lumbar interbody spine fusion at no more than 3 adjacent levels between C2 and T1 or between L1 and S1;
- Subject has undergone cervical or lumbar interbody spine fusion using NMP Fibers;
- Subject must be 18 years of age or older at the time of consent;
- Subject must be willing and able to sign an informed consent document;
- Subject must be willing and able to return to the study clinic for all follow-up visits, agree to participate in post-operative clinical and radiographic evaluations.
You may not qualify if…
- Subject is under 18 years of age at the time of consent;
- Subject is currently experiencing major mental illness (psychosis, schizophrenia, major affective disorder) which in the opinion of the investigator may indicate that the symptoms are psychological rather than of physical origin;
- Subject is currently imprisoned.
Where it is running
- Alabama Back Institute — Jasper, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.